SEC Form 4 · accession 0001225208-19-000438
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael F Mahoney
Officer — Chairman, President & CEO · Director
Period of report
Jan 1, 2019
Accepted (ET)
Jan 3, 2019 · 4:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 9, 2018 | G | 31,800 | $0.00 | D | 1,757,972 | D | |
| Common StockF1 | Jan 1, 2019 | M | 132,328 | $0.00 | A | 1,890,300 | D | |
| Common Stock | Jan 1, 2019 | F | 54,758 | $35.34 | D | 1,835,542 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance Share UnitsF1,F2 | — | Jan 1, 2019 | M | 132,328 | D | Dec 31, 2018 | Dec 31, 2018 | Common Stock | 132,328 | 0 | D |
Explanation of responses
- F1On February 22, 2016, the reporting person was awarded a target number of performance share units under the Company's 2016 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2016 adjusted free cash flow measured against its 2016 financial plan over the one-year performance period ending December 31, 2016 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ends on December 31, 2018.
- F2Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.